Kontrol Technologies Launches Development of Kontrol BioWater, an Extension of the Kontrol BioCloud™ Technology for Early Viral Detection in Water Systems
Kontrol Technologies Corp. (NEO:KNR, OTCQB:KNRLF) is advancing its technology portfolio with the launch of Kontrol BioWater, building on its existing BioCloud technology for early viral detection in wastewater systems. With a budget of $300,000 allocated for R&D, the new system aims for real-time, cloud-based monitoring. This innovation supports public health strategies by providing rapid insights into viral presence, crucial for COVID-19 monitoring. However, the company acknowledges the uncertainty surrounding future government funding for its projects.
- Launch of Kontrol BioWater extends existing technology.
- Allocated $300,000 for initial R&D phase.
- Real-time detection aims to improve public health responses.
- No assurance of future government funding for development.
“We look forward to advancing the Kontrol BioWater technology.
Early Viral Detection in Wastewater
Management believes that there is growing strategic interest and focus on early viral detection in wastewater systems. According to the following statement from the
As per the
What makes Kontrol BioWater Unique
The Kontrol BioWater technology will be designed with the goal of being the first real-time, in the cloud, detection technology for virus in wastewater. The current process for the collection of wastewater sampling involves on-site technicians, transporting samples to a laboratory and then undertaking a separate analysis of the wastewater. This process is time consuming and can take a number of days to complete. The intention of the Kontrol BioWater is to advance sampling automation for faster, on-site detection which can potentially accelerate a response plan.
“In our view, early viral detection is in its infancy, and we look forward to continuing to build our technology solutions to provide greater visibility, analytics and support for strategic initiatives undertaken by communities and governments,” says
Kontrol BioWater Innovation
The Company has launched the development of the Kontrol BioWater and has budgeted
Similar to the approach taken with the Kontrol BioCloud, the Company will seek government funding to support its research and development. The Company has demonstrated a successful track record in accessing Federal and Provincial funding for its Kontrol BioCloud technology. However, there is no assurance that the Company will receive any further government funding.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol BioCloudTM
Kontrol BioCloud (“BioCloud”) is an operating subsidiary of Canadian public company
Kontrol BioWater is a technology extension of the Kontrol BioCloud and will be developed to operate as a branded solution for water monitoring applications.
Additional information about
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Forward-looking information contained in this press releases includes, but is not limited to, the following: future testing to be conducted by
Where
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all; that the Company’s technologies will not prove as effective as expected; that customers and potential customers will not be as accepting of the Company's product and service offering as expected and/or that demand for such products and services will not continue; that the Company’s test results will not be replicated in the future or that future testing will not be conducted; that the Company will not maintain its existing relationships or contracts on the same terms or at all; and government and regulatory factors impacting the energy conservation industry. Kontrol BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005949/en/
CEO
info@kontrolcorp.com
Tel: (905) 766.0400
Investor Relations:
KNRLF@mzgroup.us
Tel: +1 (949) 546.6326
Source:
FAQ
What is Kontrol Technologies Corp. planning with Kontrol BioWater?
How much funding is allocated for the development of Kontrol BioWater?
What does Kontrol BioWater aim to achieve?
Is there a guarantee for government funding for Kontrol BioWater?